Ollin Biosciences, Inc.
1 clinical trials · Sponsor
◉ Watch Ollin Biosciences, Inc.
| Record | Firm | Date |
|---|---|---|
| A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Intravitreal OLN324 (NCT07484074) | Ollin Biosciences, Inc. | 2025-02-12 |
Track Ollin Biosciences, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.